Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MLTX compared with OCUL: revenue, margins and what each company keeps, and the suppliers and customers both name
MLTX
MoonLake Immunotherapeutics
Change
Mkt cap
Revenue
Revenue
OCUL
Ocular Therapeutix, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MLTX
MoonLake Immunotherapeutics
vs
OCUL
Ocular Therapeutix, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MLTX, solid
OCUL, dashed
MLTX
MoonLake Immunotherapeutics
Change
10.80
· pre 10.79
· delayed
Mkt cap
$919.2M
Revenue
—
Revenue
—
OCUL
Ocular Therapeutix, Inc
Change
6.43
· pre 6.50
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.4B
Revenue
$13M
Q2 FY26
Revenue
$52M
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
MLTX
MoonLake Immunotherapeutics
vs
OCUL
Ocular Therapeutix, Inc
10.80
pre 10.79
delayed
Price
6.43
pre 6.50
delayed
$919.2M
Mkt cap
$1.4B
—
Revenue
$13M
Q2 FY26
—
Revenue
$52M
FY25
Change
Change
MLTX
10.80
vs
OCUL
6.43
Pre-market
Nov 6 '26
delayed